NCT04921930View on ClinicalTrials.gov

Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 6, 2022

Primary Completion Date

April 17, 2024

Study Completion Date

April 17, 2024

Conditions
Friedreich Ataxia
Interventions
DRUG

Artesunate Oral Product

Dose escalation intake of artesunate

Trial Locations (1)

Unknown

Centre d'Investigation Clinique, hôpital Necker Enfants Malades, Paris

Sponsors

Collaborators (1)

Imagine Institute
All Listed Sponsors
collaborator

Imagine Institute

OTHER

lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV